Repositorio Dspace

Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer: A study by the PANTHEIA- SEOM group.

Mostrar el registro sencillo del ítem

dc.contributor.author Carmona-Bayonas, Alberto
dc.contributor.author Marino-Mendez, Axel
dc.contributor.author Vicente-Conesa, María-Ángeles
dc.contributor.author Jiménez-Fonseca, Paula
dc.contributor.author de-Toro-Carmena, María
dc.contributor.author Guillen-Ponce, Carmen
dc.contributor.author Lamarca, Angela
dc.contributor.author Benavente, Mónica
dc.contributor.author Gallego, Javier
dc.contributor.author Cerda-Serda, Paula
dc.contributor.author Hernández-San-Gil, Raquel
dc.contributor.author Vega-Cano, Kreina-Sharela
dc.contributor.author López, Ana
dc.contributor.author Soriano-Tabares-de-Navas, María-Luisa
dc.contributor.author Peiro, Inmaculada
dc.contributor.author Parra-Paladines, Wagner
dc.contributor.author Zwisler-Contreras, Patricia
dc.contributor.author Brozos-Vázquez, Elena
dc.contributor.author Cabezon-Gutiérrez, Luis
dc.contributor.author Munoz-Martin, Andrés
dc.contributor.author Pacheco-Barcia, Vilma
dc.date.accessioned 2026-11-11T09:07:19Z
dc.date.available 2026-11-11T09:07:19Z
dc.date.issued 2026-11
dc.identifier.citation Carmona-Bayonas A, Mariño Méndez A, Vicente-Conesa MÁ, Jimenez-Fonseca P, De Toro Carmena M, Guillen-Ponce C, et al. Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer: A study by the PANTHEIA- SEOM group. Pancreatology. noviembre de 2026;26(7):995-1004. doi:10.1016/j.pan.2026.08.008
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/29203
dc.description.abstract BACKGROUND: Systemic inflammation is a key driver of progression in pancreatic ductal adenocarcinoma (PDAC). We aimed to externally validate the Systemic Inflammation Response Index (SIRI) and define its non-linear prognostic value in a large multicenter cohort. METHODS: We analyzed 672 patients with metastatic PDAC receiving first-line chemotherapy across 30 centers. SIRI was assessed using a validated cut-off (>2.3) and as a log-transformed continuous variable in multivariable Weibull accelerated failure-time models with restricted cubic splines. RESULTS: Patients with low SIRI (?2.3) had longer median OS (14.0 vs 9.2 months; p < 0.001) and PFS (5.9 vs 3.9 months; p < 0.001) than those with high SIRI. High SIRI was associated with a lower objective response rate (25% vs 37%; p < 0.001). In multivariable analyses, higher SIRI independently predicted inferior OS and PFS (75th vs 25th percentile: HR 1.14 [95% CI 1.05-1.25], HR 1.11 [95% CI 1.03-1.21]) and poorer tumor response (OR 0.78; 95% CI 0.62-1.00). Higher SIRI correlated with greater hepatic tumor burden and cachexia. CONCLUSIONS: SIRI is a robust, independent prognostic marker in metastatic PDAC. Higher values identify a phenotype with inferior survival and poorer tumor response. An open-access web calculator is provided to illustrate and explore the nonlinear, continuous prognostic gradient of SIRI and its impact on outcome.
dc.language.iso eng
dc.publisher ELSEVIER BV
dc.rights Atribución/Reconocimiento 4.0 Internacional
dc.rights.uri https://creativecommons.org/licenses/by/4.0/deed.es *
dc.subject.mesh Humans
dc.subject.mesh Pancreatic Neoplasms/drug therapy/pathology
dc.subject.mesh Female
dc.subject.mesh Male
dc.subject.mesh Aged
dc.subject.mesh Middle Aged
dc.subject.mesh Carcinoma, Pancreatic Ductal/drug therapy/pathology
dc.subject.mesh Inflammation/pathology
dc.subject.mesh Prognosis
dc.subject.mesh Treatment Outcome
dc.subject.mesh Antineoplastic Agents/therapeutic use
dc.subject.mesh Neoplasm Metastasis
dc.subject.mesh Cohort Studies
dc.title Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer: A study by the PANTHEIA- SEOM group.
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 42601286
dc.relation.publisherversion https://linkinghub.elsevier.com/retrieve/pii/S1424390326008793
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.1016/j.pan.2026.08.008
dc.journal.title Pancreatology : Official Journal of the International Association of Pancreatology (Iap) ... [Et Al.]
dc.identifier.essn 1424-3911


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta